Benefit of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: trial sequential analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benefit of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: trial sequential analysis

Published:2024-05-20 Issue:9 Volume:110 Page:5905-5906
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Chen I-Wen¹,Yu Ting-Sian²,Hung Kuo-Chuan³

Affiliation:

1. Department of Anesthesiology, Chi Mei Medical Center, Liouying

2. Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan

3. Department of Anesthesiology, Chi Mei Medical Center, Tainan City

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference3 articles.

1. Comparison of efficacy and safety between neoadjuvant chemotherapy and neoadjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis;Xu;Int J Surg (London, England),2024

2. Trial sequential analysis: plain and simple;De Cassai;Korean J Anesthesiol,2021

3. Impact of intravenous vitamin C as a monotherapy on mortality risk in critically ill patients: a meta-analysis of randomized controlled trials with trial sequential analysis;Hung;Front Nutr,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP